Live tape
Top 8, mentions 7d6,695GOOGL1,301 mentions▲ +0.05SPCX1,203 mentions▲ +0.08NVDA1,091 mentions▲ +0.09MSFT781 mentions▲ +0.04META609 mentions▲ +0.04QQQ586 mentions▲ +0.08AMZN563 mentions▲ +0.07ADBE561 mentions▲ +0.03

Equity · Healthcare

IDXX

NASDAQ

IDEXX Laboratories, Inc.

$511 +0.79% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 18, 2026
Price · Chart
48 sessions
$600 $500 14 Jul 18 Sep

The line runs $540.66 on 14 July through $511 on 18 September, on a scale from $500 to $600. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 48 sessions, 14 Jul – 18 Sep 2026
Market cap $40.3B
P/E (TTM) 35.9
52-week range $505 – $766.67
Avg volume 43.1K

as of Sep 18, 2026

IDXX insider trades

SEC Form 4 · last 90 days · newest reported trade 4 Sep 2026
Open-market buys 0
Open-market sells 1
Net sold $1.17M
Non-trade filings 4
Date Insider Type Shares Value
04 Sep 2026 Kingsley Lawrence D Director Sell 2,203 $1.17M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
04 Sep 2026 Kingsley Lawrence D Director Option exercise 2,203 $252K
20 Aug 2026 Emerson Andrew EVP, CFO and Treasurer Option exercise 265 $47K
20 Aug 2026 Emerson Andrew EVP, CFO and Treasurer Tax withheld 86
30 Jul 2026 HOOLEY JOSEPH L Director Award 49 $27K

IDXX reported financials

SEC EDGAR XBRL SEC EDGAR

IDXX reported revenue of $4.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was $1.1B.

Figure Reported Period
Revenue $4.3B 31 Dec 2025 fiscal year
Net income $1.1B 31 Dec 2025 fiscal year
Diluted EPS $13.08 31 Dec 2025 fiscal year
Total assets $3.4B 30 Jun 2026 at period end
Total equity $1.6B 30 Jun 2026 at period end

IDXX earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $4.27 $1.22B
31 Mar 2026 Q1 2026 $3.47 $1.14B
31 Dec 2025 FY 2025 $13.08 $4.30B
30 Sep 2025 Q3 2025 $3.40 $1.11B
30 Jun 2025 Q2 2025 $3.63 $1.11B
31 Mar 2025 Q1 2025 $2.96 $998M
31 Dec 2024 FY 2024 $10.67 $3.90B
30 Sep 2024 Q3 2024 $2.80 $976M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

IDXX institutional holders

SEC Form 13F SEC EDGAR

11 of the 45 institutional funds we track reported a IDXX position for the quarter ended 30 Jun 2026 — a combined $930.7M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Fundsmith Trimmed −30.4% shares 1,019,887 $536.9M
Point72 Asset Management Added +103.4% shares 262,905 $138.4M
Renaissance Technologies Added +126.3% shares 109,784 $57.8M
Marshall Wace Added +88.9% shares 93,128 $49.0M
Millennium Management Held (±25%) +12.1% shares 78,980 $41.6M
AQR Capital Management Held (±25%) −20.2% shares 77,198 $40.4M
Man Group Added +48.8% shares 51,382 $27.0M
Citadel Advisors Trimmed −55.6% shares 38,846 $20.5M
Bridgewater Associates Added +225.1% shares 33,528 $17.7M
Balyasny Asset Management Added +38.2% shares 1,808 $952K

Showing the 10 largest of 11 reported positions. The figures above count all of them.

IDXX fails-to-deliver

SEC CNS data SEC

On 11 Sep 2026, 2 shares of IDXX failed to deliver (about $1K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
11 Sep 2026 2 $1K <0.001%
10 Sep 2026 824 $424K 0.001%
28 Aug 2026 47 $26K <0.001%

Congressional trades in IDXX

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in IDXX is a sale by April McClain Delaney (house, MD), dated 16 Oct 2025.

Date Member Type Amount
16 Oct 2025 filed 04 Nov 2025 April McClain Delaney house · Democrat–MD Sale $1K–$15K
04 Sep 2025 filed 07 Oct 2025 Byron Donalds house · Republican–FL Purchase $1K–$15K
07 Aug 2025 filed 02 Sep 2025 April McClain Delaney house · Democrat–MD Sale $1K–$15K
09 Jul 2025 filed 05 Aug 2025 April McClain Delaney house · Democrat–MD Sale $1K–$15K
15 May 2025 filed 09 Jun 2025 Robert P. Bresnahan, Jr. house · Republican–PA Purchase $1K–$15K
12 May 2025 filed 22 Jun 2025 Jefferson Shreve house · Republican–IN Sale $100K–$250K
09 Apr 2025 filed 02 May 2025 April McClain Delaney house · Democrat–MD Purchase $1K–$15K
08 Apr 2025 filed 28 Apr 2025 Robert P. Bresnahan, Jr. house · Republican–PA Sale $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings
  8. Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Idexx_Laboratories